PRV
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here’s Why That’s a Smart Move.
Business
Jessica Roberts
Hot off the approval of its gene therapy for a pair of rare hereditary blood disorders, Vertex Pharmaceuticals (NASDAQ: VRTX) will soon ...
